Literature DB >> 17034537

FK506 increases pigmentation and migration of human melanocytes.

H Y Kang1, Y M Choi.   

Abstract

BACKGROUND: Topical tacrolimus (FK506) is a potential therapeutic option for vitiligo management. Despite its clinical efficacy, the underlying mechanism of how topical tacrolimus induces repigmentation in vitiligo has scarcely been investigated.
OBJECTIVES: To investigate the direct effects of FK506 on pigmentation and migration of human melanocytes.
METHODS: Cell proliferation was measured using a Coulter counter. The effects on pigmentation were investigated by measuring melanin contents, tyrosinase activity and tyrosinase expression. To determine the effects of FK506 on cell migration, we performed scratch assays and Boyden chamber assays.
RESULTS: FK506 treatment increased melanin contents, although there was an inhibitory effect on growth of melanocytes. The increase of pigmentation was due to the result of the stimulatory action of FK506 on tyrosinase activity and its expression, which eventually led to melanin biosynthesis. Furthermore, cell migration was enhanced by FK506 treatment.
CONCLUSIONS: These findings provide in vitro evidence demonstrating direct effects of FK506 on pigmentation and melanocyte migration and may provide a possible mechanism for the effect of tacrolimus in vitiligo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034537     DOI: 10.1111/j.1365-2133.2006.07467.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

Review 1.  Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.

Authors:  Stanca A Birlea; Gertrude-E Costin; Dennis R Roop; David A Norris
Journal:  Med Res Rev       Date:  2016-12-28       Impact factor: 12.944

2.  A pilot study of 1% pimecrolimus cream for the treatment of childhood segmental vitiligo.

Authors:  Woo-Haing Shim; Sung-Won Suh; Seung-Wook Jwa; Margaret Song; Hoon-Soo Kim; Hyun-Chang Ko; Byung-Soo Kim; Moon-Bum Kim
Journal:  Ann Dermatol       Date:  2013-05-10       Impact factor: 1.444

3.  Hyperpigmentation in photo exposed patches of vitiligo following tacrolimus therapy.

Authors:  Kanika Sahni; Vishal Gupta; Neena Khanna
Journal:  Indian Dermatol Online J       Date:  2014-04

4.  Pimecrolimus increases the melanogenesis and migration of melanocytes in vitro.

Authors:  Ping Xu; Jie Chen; Cheng Tan; Ren-Sheng Lai; Zhong-Sheng Min
Journal:  Korean J Physiol Pharmacol       Date:  2017-04-21       Impact factor: 2.016

5.  Treatment Strategies for Hypopigmentation in the Context of Burn Hypertrophic Scars.

Authors:  Bonnie C Carney; Jacqueline P McKesey; Dean S Rosenthal; Jeffrey W Shupp
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-01-18

6.  Double-blind, placebo-controlled, randomized study comparing 0.0003% calcitriol with 0.1% tacrolimus ointments for the treatment of endemic pityriasis alba.

Authors:  Berenice Moreno-Cruz; Bertha Torres-Álvarez; Diana Hernández-Blanco; Juan Pablo Castanedo-Cazares
Journal:  Dermatol Res Pract       Date:  2012-04-22

7.  Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser.

Authors:  Said Hilton; Heike Heise; Bettina Alexandra Buhren; Holger Schrumpf; Edwin Bölke; Peter Arne Gerber
Journal:  Eur J Med Res       Date:  2013-11-14       Impact factor: 2.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.